Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Illinois

Chicago Illinois

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

New York

New York New York 10065

A clinical research study of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific or Unspecified Childhood Solid Tumor, Protocol Specific

New York New York 10065

Patients are needed to participate in a clinical research study evaluating EBV-specific T-cells for the treatment of Non-Hodgkin's Lymphoma or Epstein-Barr Virus

Rochester New York 14642

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Ohio

Columbus Ohio 43210

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Texas

Houston Texas

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Australia

UPDATED

Parkville Victoria 3052

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Randwick New South Wales 2031

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

South Brisbane Queensland 4101

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Westmead 2145

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Austria

UPDATED

Graz 8036

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Innsbruck 6020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Wien 1090

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Belgium

UPDATED

Brussels 1200

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Brussels 1020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Ghent 9000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Leuven 3000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Liège 4000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Czech Republic

UPDATED

Praha 5 150 06

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Denmark

UPDATED

Kobenhavn O 2100

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

France

UPDATED

Bordeaux 33076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Marseille cedex 5 13385

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Paris 75019

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Paris 75012

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Germany

UPDATED

Berlin 13353

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Duesseldorf 40225

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Essen 45122

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Frankfurt 60590

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Hamburg 20246

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

View More ▼

UPDATED

Jena 07740

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Kiel 24105

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Munich 80337

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Munster 48149

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Tübingen 72076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Ulm 89075

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Würzburg 97080

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Israel

UPDATED

Haifa 31096

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Jerusalem 91120

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Petah Tikva 49202

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Tel Aviv 64239

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Tel Hashomer 52621

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Italy

UPDATED

Bologna 40138

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Genova 16147

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Monza (MB) 20900

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Napoli 80123

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Padova 35128

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)